Skye Bioscience, Inc. Operating Cash Flow
Skye Bioscience, Inc. (SKYE) reported Operating Cash Flow of -$15.68 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- Skye Bioscience, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$7.12M.
- Skye Bioscience, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$8.56M.
- Skye Bioscience, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$9.77M.
- Skye Bioscience, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$13.36M.
- Skye Bioscience, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$43.06M.
- Skye Bioscience, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$25.24M.
- Skye Bioscience, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$13.95M.
- Skye Bioscience, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$12.74M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$7.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$15.68M 10-Q · filed 2026-08-14 | -$25.45M derived: sum of 3 quarters · filed 2026-08-14 | -$38.81M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$8.56M 10-Q · filed 2026-05-11 | -$18.32M derived: sum of 2 quarters · filed 2026-05-11 | -$31.69M derived: sum of 3 quarters · filed 2026-05-11 | -$42.43M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$9.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$23.13M derived: sum of 2 quarters · filed 2026-03-10 | -$33.88M derived: sum of 3 quarters · filed 2026-08-14 | -$43.06M 10-K · filed 2026-03-10 | |
| 2025-09-30 | -$13.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$24.11M derived: sum of 2 quarters · filed 2026-08-14 | -$33.30M 10-Q · filed 2025-11-10 | -$41.47M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$10.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$19.93M 10-Q · filed 2026-08-14 | -$28.10M derived: sum of 3 quarters · filed 2026-08-14 | -$33.37M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$9.19M 10-Q · filed 2026-05-11 | -$17.36M derived: sum of 2 quarters · filed 2026-05-11 | -$22.62M derived: sum of 3 quarters · filed 2026-05-11 | -$29.71M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | -$8.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$13.44M derived: sum of 2 quarters · filed 2026-03-10 | -$20.53M derived: sum of 3 quarters · filed 2026-03-10 | -$25.24M 10-K · filed 2026-03-10 | |
| 2024-09-30 | -$5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$12.36M derived: sum of 2 quarters · filed 2025-11-10 | -$17.06M 10-Q · filed 2025-11-10 | -$20.91M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | -$7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$11.80M 10-Q · filed 2025-08-07 | -$15.65M derived: sum of 3 quarters · filed 2025-08-07 | -$19.70M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | -$4.71M 10-Q · filed 2025-05-08 | -$8.55M derived: sum of 2 quarters · filed 2025-05-08 | -$12.61M derived: sum of 3 quarters · filed 2025-05-08 | -$14.60M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$7.90M derived: sum of 2 quarters · filed 2025-03-20 | -$9.89M derived: sum of 3 quarters · filed 2025-03-20 | -$13.95M 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$4.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$6.05M derived: sum of 2 quarters · filed 2024-11-07 | -$10.11M 10-Q · filed 2024-11-07 | -$14.98M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$6.05M 10-Q · filed 2024-08-09 | -$10.92M derived: sum of 3 quarters · filed 2024-08-09 | -$12.98M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | -$4.06M 10-Q · filed 2024-05-10 | -$8.93M derived: sum of 2 quarters · filed 2024-05-10 | -$10.99M derived: sum of 3 quarters · filed 2024-05-10 | -$13.89M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | -$4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$6.93M derived: sum of 2 quarters · filed 2024-03-22 | -$9.83M derived: sum of 3 quarters · filed 2024-03-22 | -$12.74M 10-K · filed 2024-03-22 | |
| 2022-09-30 | -$2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$4.96M derived: sum of 2 quarters · filed 2023-11-14 | -$7.87M 10-Q · filed 2023-11-14 | -$9.84M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$5.82M 10-Q · filed 2023-08-07 | -$5.82M 10-Q · filed 2022-08-15 | -$7.78M derived: sum of 3 quarters · filed 2023-08-07 | -$9.27M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$2.91M 10-Q · filed 2023-05-12 | -$4.88M derived: sum of 2 quarters · filed 2023-05-12 | -$6.37M derived: sum of 3 quarters · filed 2023-05-12 | -$8.04M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$3.46M derived: sum of 2 quarters · filed 2023-03-31 | -$5.13M derived: sum of 3 quarters · filed 2023-03-31 | -$6.47M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$3.16M derived: sum of 2 quarters · filed 2022-11-14 | -$4.51M 10-Q · filed 2022-11-14 | -$6.29M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$3.02M 10-Q · filed 2022-08-15 | -$4.81M derived: sum of 3 quarters · filed 2022-08-15 | -$6.78M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$1.35M 10-Q · filed 2022-05-06 | -$3.13M derived: sum of 2 quarters · filed 2022-05-06 | -$5.11M derived: sum of 3 quarters · filed 2022-05-06 | -$6.14M derived: sum of 4 quarters · filed 2022-05-06 | |
| 2020-12-31 | -$1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$3.76M derived: sum of 2 quarters · filed 2022-03-28 | -$4.79M derived: sum of 3 quarters · filed 2022-03-28 | -$6.05M 10-K · filed 2022-03-28 | |
| 2020-09-30 | -$1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$3.00M derived: sum of 2 quarters · filed 2021-11-10 | -$4.27M 10-Q · filed 2021-11-10 | -$5.77M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$2.29M 10-Q · filed 2021-08-06 | -$3.80M derived: sum of 3 quarters · filed 2021-08-06 | -$5.29M derived: sum of 4 quarters · filed 2021-08-06 | |
| 2020-03-31 | -$1.27M 10-Q · filed 2021-05-07 | -$2.77M derived: sum of 2 quarters · filed 2021-05-07 | -$4.26M derived: sum of 3 quarters · filed 2021-05-07 | -$5.86M derived: sum of 4 quarters · filed 2021-05-07 | |
| 2019-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$2.99M derived: sum of 2 quarters · filed 2021-03-02 | -$4.60M derived: sum of 3 quarters · filed 2021-03-02 | -$6.03M 10-K · filed 2021-03-02 | |
| 2019-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$3.09M derived: sum of 2 quarters · filed 2020-11-06 | -$4.52M 10-Q · filed 2020-11-06 | -$5.54M derived: sum of 4 quarters · filed 2020-11-06 | |
| 2019-06-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$3.04M 10-Q · filed 2020-08-13 | -$4.05M derived: sum of 3 quarters · filed 2020-08-13 | -$4.87M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | -$1.43M 10-Q · filed 2020-05-08 | -$2.45M derived: sum of 2 quarters · filed 2020-05-08 | -$3.26M derived: sum of 3 quarters · filed 2020-05-08 | -$4.32M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2018-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | -$1.83M derived: sum of 2 quarters · filed 2020-03-23 | -$2.89M derived: sum of 3 quarters · filed 2020-03-23 | -$3.94M 10-K · filed 2020-03-23 | |
| 2018-09-30 | -$816.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$1.88M derived: sum of 2 quarters · filed 2019-11-14 | -$2.93M 10-Q · filed 2019-11-14 | -$5.07M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | -$1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$2.11M 10-Q · filed 2019-08-09 | -$4.26M derived: sum of 3 quarters · filed 2019-08-09 | -$4.36M derived: sum of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | -$1.05M 10-Q · filed 2019-05-10 | -$3.20M derived: sum of 2 quarters · filed 2019-05-10 | -$3.30M derived: sum of 3 quarters · filed 2019-05-10 | ||
| 2017-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$2.24M derived: sum of 2 quarters · filed 2019-03-14 | -$3.33M 10-K · filed 2019-03-14 | ||
| 2017-09-30 | -$99.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$1.19M 10-Q · filed 2018-11-14 | |||
| 2017-06-30 | -$1.09M 10-Q · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |